Trials in Start-Up

MASC Trials brings together health professionals to coordinate clinical trials across our numerous melanoma and skin cancer trial sites located at hospitals and clinics throughout Australia and overseas.

The trials in start-up listed on this page are fully approved but are not yet accepting patients. Click on the trial names below for further information about these trials.

MASC Trials cannot enrol patients into a trial.

Learn how to participate in one of our clinical trials here.

Melanoma

Squamous Cell Carcinoma

05.21 BETTER

Bevacizumab and immune chEckpoint inhibitors plus hypofractionated stereotactic radioTherapy for the treatment of sympTomatic mElanoma bRain metastases

Chair

Associate Professor Tim Wang

Registration ID

TBC

Trial Status

Trial in Start-Up

MASC Trials Contact

hello@masc.org.au

01.21 SiroSkin

A multi-centre, randomised, double-blind, placebo-controlled trial of 1% topical Sirolimus in the chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients

Chair

Professor Kiarash Khosrotehrani

Registration ID

Trial Status

Trial in Start-Up

MASC Trials Contact

siroskin@masc.org.au